Co-Diagnostics Expands Vector Control Customer Base To 25 Customers Across 15 U.S. States, Following An Installation In Nevada Next Week
Portfolio Pulse from Benzinga Newsdesk
Co-Diagnostics, Inc. (NASDAQ:CODX) announced the expansion of its vector control technology to 25 customers across 15 U.S. states, with a new installation in Nevada next week. The company's Vector Smart® PCR tests are used for environmental surveillance of mosquito-borne illnesses.
July 02, 2024 | 1:33 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Co-Diagnostics, Inc. is expanding its vector control technology to 25 customers across 15 U.S. states, including a new installation in Nevada next week. This expansion could lead to increased revenue and market presence for the company.
The expansion of Co-Diagnostics' vector control technology to more states and customers is likely to increase the company's revenue and market presence. The installation in Nevada signifies ongoing growth and adoption of their technology.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100